SAROJ NAMRATA enters OCULAR THERAPEUTIX, INC with 200K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/23/2025ACC: 0001104659-25-061849
Officer· Chief Business Officer
Since Jun 2025
200K
Baseline shares
100% direct
200K
Direct ownership
1 position
466K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned200K
Total
200K direct200K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 200K | Direct |
| Total | 200K | 200K direct |
Derivative Holdings3
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
50K
Shares owned
N/A
Exercise price
9.95
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
316K
Shares owned
N/A
Exercise price
10.27
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
9.95
Expiration
—
Exercise window
—
Total
Underlying
466K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 9.95 | — | — | 50K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 10.27 | — | — | 316K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 9.95 | — | — | 100K | N/A |
| Total | 466K | 0.00 | ||||